 |
½ÅÀç±¹
|
ADMET/Pharmacokinetics Technology Platform for Drug Discovery and Development: In vitro to In vivo Translation (ÃÊû°¿¬ )
|
|
Áß¿ÜÁ¦¾à Áß¾Ó¿¬±¸¼Ò ÃÊû¼¼¹Ì³ª / 2010.08.20 [LINK ] |
|
 |
|
|
 |
·ù±¤Çö, ±èÈ£¼÷, ÃÖÁö¿±
|
Metabolomics study for the prediction of drug response of antihypertensive (±¸µÎ¹ßÇ¥ )
|
|
KOGOÇѱ¹À¯ÀüüÇÐȸ 2010 Á¤±âÇмú´ëȸ / 2010.09.09-09.10 [LINK ] |
|
 |
|
|
 |
½ÅÀç±¹
|
ºÎ»ê¹éº´¿ø ¿¬±¸ÀÎÇÁ¶ó ¹× ÀÓ»ó½ÃÇè¼¾ÅÍ ¼Ò°³ (ÃÊû°¿¬ )
|
|
ÇØ¿î´ë¹éº´¿ø ±³¼ö°³¹ß¿öÅ©¼¥ / 2010.8.14, 9.11 [LINK ] |
|
 |
|
|
 |
½ÅÀç±¹
|
Early Phase Clinical Trial of Development of Herbal Medicine : Current Status (ÃÊû°¿¬ )
|
|
½ÄǰÀǾàǰ¾ÈÀüû »ý¾àÁ¦Á¦°ú ¼¼¹Ì³ª / 2010.07.09 [LINK ] |
|
 |
|
|
 |
½ÅÀç±¹
|
¿¬±¸ ÀÎÇÁ¶ó ±¸Ãà¹æÇâ (±¸µÎ¹ßÇ¥ )
|
|
[»ó°è¹éº´¿ø] ±³¼ö°³¹ß¿öÅ©¼¥(¿¬±¸¿ª·® °È) / 2010.07.03 [LINK ] |
|
 |
|
|
 |
½ÅÀç±¹
|
±¹°¡ °íÈ¿À² ½Å¾à°³¹ß ÀÎÇÁ¶ó ±¸ÃàÀÇ ÇöȲ ¹× ÇâÈÄ ¹ßÀü ¹æ¾È: DMPK technology platform in vitro to in vivo (±¸µÎ¹ßÇ¥ )
|
|
[HT Æ÷·³] Á¦1ȸ ½Å¾à¡¤ÀÇ·á±â±â°³¹ß¡¤ÀÓ»ó½ÃÇèºÐ°ú Àü¹®°¡ ÃÊû Á´ãȸ / 2010.06.22 [LINK ] |
|
 |
|
|
 |
¼ÕÁöÈ«
|
AMS¸¦ ÀÌ¿ëÇÑ microdosing ¿¬±¸ (±¸µÎ¹ßÇ¥ )
|
|
2010³âµµ ´ëÇÑÀÓ»ó¾à¸®ÇÐȸ Ãá°è½ÉÆ÷Áö¾ö / 2010.5.28 [LINK ] |
|
 |
|
|
 |
¼ÛÀÓ¼÷
|
|
Á¦4ȸ NRL ½ÉÆ÷Áö¿ò_¾à¹° ¼ö¼Û, ´ë»ç ¹× ¼Û´ÞÀÇ ÇÕ¸ñÀûÀû ÅëÇÕ / 2010.5.25-5.26 [LINK ] |
|
 |
|
|
 |
½ÅÀç±¹
|
How close are we to personalized pharmacotherapy based on pharmacogenomics biomarker? (±¸µÎ¹ßÇ¥ )
|
|
2010³âµµ (ÅëÇÕ) »ýÈÇкÐÀÚ»ý¹°ÇÐȸ ±¹Á¦Çмú´ëȸ / 2010.5.19 [LINK ] |
|
 |
|
|
 |
½ÅÀç±¹
|
ÀÓ»ó½ÃÇèÀÇ °³¿ä ¹× °ü·Ã ¹ý±Ô (ÃÊû°¿¬ )
|
|
ÇØ¿î´ë¹éº´¿ø ÀÓ»ó½ÃÇè½É»çÀ§¿øÈ¸ ÀÓ»ó½ÃÇè°ú IRB ½ÉÀÇ¿¡ ´ëÇÑ ÀÌÇØ / 2010.5.13 [LINK ] |
|
 |
|